Status:
RECRUITING
New MRI Biomarkers in Head and Neck Cancers
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Conditions:
Head and Neck Cancer
Thyroid Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Magnetic resonance imaging (MRI) is a diagnostic technique that takes pictures of organs of the body. It uses magnetic fields and radio waves that cannot be felt. This makes specific organs, blood ves...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Group 1 patients: Presence of a suspicious metastatic lesion or suspicious for recurrent disease in the head and neck region.
- Group 2 patients:
- Biopsy proven recurrent or metastatic or definitive head and neck cancer or (differentiated and undifferentiated) thyroid cancers in the head and neck region only.
- Patients planning to undergo reatment at MSK
Exclusion
- Patient would require anesthesia for the study
- Patients who are claustrophobic
- Patients selecting treatment outside of MSK
- Known reaction to Gd based contrast agent
- Patients who have presence of a known contradiction to MRI
- Pacemaker
- Aneurysm clips
- Patients with implants that are contradicted for MR imaging will be excluded
- Pregnant
- Age and mental status wherein he /she is unable to cooperate for MRI study
Key Trial Info
Start Date :
March 16 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03483337
Start Date
March 16 2018
End Date
March 1 2026
Last Update
February 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065